Compliance therapy: An intervention targeting insight and treatment adherence in psychotic patients

Behavioural and Cognitive Psychotherapy

Volumn 24, Issue 4, 1996, Pages 331-350

  Kemp, Roisin ^a   David, Anthony ^a   Hayward, Peter ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ACUTE PSYCHOSIS; ADULT; ARTICLE; CASE REPORT; COGNITIVE THERAPY; FEMALE; HUMAN; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT OUTCOME;

EID: 0030479671     PISSN: 13524658     EISSN: None     Source Type: Journal    
DOI: 10.1017/s135246580001523x     Document Type: Article

References (41)

1. ADAMS, S.G. and HOWE, J.T. (1993). Predicting medication compliance in a psychotic population. Journal of Nervous and Mental Disease 181, 558-560.
2. ALFORD, B.A. and CORREIA, C.J. (1994). Cognitive therapy of schizophrenia: theory and empirical status. Behaviour Therapy 25, 17-33.
3. BABIKER, I.E. (1986). Noncompliance in schizophrenia. Psychiatric Developments 4, 329-337.
4. BEBBINGTON, P.E. (1995). The content and context of compliance. International Clinical Psychopharmacology 9 (suppl 5), 41-50.
5. BLACKWELL, B. (1992). Compliance. Psychotherapy and Psychosomatics 58, 161-169.
6. BOCZKOWSKI, J.A., ZEICHNER, A. and DESANTO, N. (1985). Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. Journal of Consulting and Clinical Psychology 53(5), 666-671.
7. BROWN, C., WRIGHT, R. and CHRISTENSEN, D. (1987). Association between type of medication instruction and patient knowledge, side effects and compliance. Hospital and Community Psychiatry 34, 934-938.
8. CORRIGAN, P.W., LIBERMAN, R.P. and ENGEL, J.D. (1990). From noncompliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry 41, 1203-1211.
9. DAVID, A.S. (1990). Insight and psychosis. British Journal of Psychiatry 156, 798-808.
10. DIAMOND, R.J. (1983). Enhancing medication use in schizophrenic patients. Journal of Clinical Psychiatry 44, 7-14.
11. ECKMAN, T.A., LIBERMAN, R.P., PHIPPS, C.C. and BLAIR, K. (1990). Teaching medication management skills to schizophrenic patients. Journal of Clinical Psychopharmacology 10, 33-38.
12. ECKMAN, T.A., WIRSHING, W.C., MARDER, S.R., LIBERMAN, R.P., JONSTON-CRONK, K., ZIMMERMAN, K. and MINTZ, J. (1992). Technique for training patients in illness self-management: a controlled trial. American Journal of Psychiatry 149, 1549-1555.
13. FALLOON, I.R.H. (1984). Developing and maintaining adherence to long-term drug-taking regimens. Schizophrenia Bulletin 10, 1549-1555.
14. FOWLER, D., GARETY, P. and KUIPERS, E. (1995). Cognitive behaviour therapy for psychosis. Chichester: Wiley.
15. GARETY, P.A., KUIPERS, L., FOWLER, D., CHAMBERLAIN, F. and DUNK, G. (1994). Cognitive behavioural therapy for drug-resistant psychosis. British Journal of Medical Psychology 67, 259-271.
16. GOLDSTEIN, M.J. (1992). Psychosocial strategies for maximizing the effects of psychotropic medications for schizophrenia and mood disorder. Psychopharmacology Bulletin 28, 237-240.
17. GORDIS, L. (1979). Conceptual and methodologic problems in measuring patient compliance. In R.B. Haynes, D.W. Taylor and D.L. Sackett (Eds). Compliance in health care. Baltimore: Johns Hopkins University Press.
18. HAWTON, K., SALKOVSKIS, P.M., KIRK, J. and CLARK, D.M. (1989). Cognitive behaviour therapy for psychiatric problems: a practical guide. Oxford: Oxford University Press.
19. HAYWARD, P., CHAN, N., KEMP, R., YOULE, S. and DAVID, A. (1995). Medication self-management: a preliminary report on an intervention to improve medication compliance. Journal of Mental Health 4, 513-519.
20. HOGAN, T.P., AWAD, A.G. and EASTWOOD, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: reliability and predictive validity. Psychological Medicine 13, 177-183.
21. KANE, J.M. (1983). Problems of compliance in the outpatient treatment of schizophrenia. Journal of Clinical Psychiatry 44, 3-6.
22. KEMP, R., HAYWARD, P., APPLEWHATTE, G., EVERITT, B. and DAVID, A. (1996). Compliance therapy in psychotic patients: a randomized controlled trial. British Medical Journal 312, 345-349.
23. KEMP, R. and DAVID, A. (1995). Insight and adherence to treatment in psychotic disorders. British Journal of Hospital Medicine 54, 222-227.
24. KEMP, R. and DAVID, A. (in press). Insight and compliance. In B. Blackwell (Ed). Compliance and the treatment alliance in serious mental illness. Newark, NJ: Gordon and Breach Publishing Group.
25. KEMP, R. and DAVID, A. (1996). Psychological predictors of insight and compliance in psychotic patients. British Journal of Psychiatry 169, 444-450.
26. KINGDON, D.G. and TURKINGTON, D. (1991). Preliminary report. The use of cognitive behaviour therapy and a normalizing rationale in schizophrenia. Journal of Nervous and Mental Disease 179, 207-211.
27. KINGDON, D.G. and TURKINGTON, D. (1994). Cognitive-behavioural therapy of schizophrenia. New York: Guilford Press.
28. KINGDON, D., TURKINGTON, D. and JOHN, C. (1994). Cognitive behaviour therapy of schizophrenia. British Journal of Psychiatry 164, 581-587.
29. KISSLING, W. (1994). Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatrica Scandinavica 89 (suppl 382), 16-24.
30. LYON, H.M., KANEY, S. and BENTALL, R.P. (1994). The defensive function of persecutory delusions: Evidence from attribution tasks. British Journal of Psychiatry 164, 637-646.
31. LUKOFF, D., LIBERMAN, R.P. and NEUCHTERLEIN, K.H. (1986). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin 12, 578-602.
32. MCEVOY, J.P., FRETER, S., EVERETT, G., GELLER, G.L., APPELBAUM, P., APPERSON, L.J. and ROTH, L. (1989). Insight and the clinical outcome of schizophrenic patients. Journal of Nervous and Mental Disease 177, 48-51.
33. MCEVOY, J.P., HOGARTY, G.E. and STEINGARD, S. (1991). Optimal dose of neuroleptic medication in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry 48, 739-745.
34. MILLER, W.R. and ROLLNICK, S. (1991). Motivational interviewing: preparing people to change. New York: Guilford Press.
35. PERRIS, C. (1989). Cognitive therapy with schizophrenic patients. New York: Guilford Press.
36. ROLLNICK, S., HEATHER, N. and BELL, A. (1992). Negotiating behaviour change in medical settings: the development of brief motivational interviewing. Journal of Mental Health 1, 25-37.
37. SELTZER, A., RONCARI, I. and GARFINKEL, P. (1980). Effect of patient education on medication compliance. American Journal of Psychiatry 25, 638-645.
38. SMITH, J., BIRCHWOOD, M. and HADDRELL, A. (1992). Informing people with schizophrenia about their illness: the effect of residual symptoms. Journal of Mental Health 1, 61-70.
39. STREICKER, S.K., AMDUR, M. and DINCIN, J. (1986). Educating patients about psychiatric medications: failure to enhance compliance. Psychosocial Rehabilitation Journal 4, 15-28.
40. TARRIER, N., BECKETT, R., HARWOOD, S., BAKER, S., YUSUPOFF, L. and UGARTEBURU, I. (1993a). A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry 162, 524-532.
41. TARRIER, N., SHARPE, L., BECKETT, R., HARWOOD, S., BAKER, A. and YUSOPOFF, L. (1993b). A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: 11. Treatment-specific changes in coping and problem-solving skills. Social Psychiatry and Psychiatric Epidemiology 28, 5-10.